Beta
Antihypertensive drugs
medication Under reviewAntihypertensive drugs are pharmaceutical medications designed to lower elevated blood pressure by targeting various physiological mechanisms involved in blood pressure regulation. Common classes include ACE inhibitors, which block the conversion of angiotensin I to angiotensin II to reduce vasoconstriction; angiotensin II receptor blockers that prevent angiotensin II from binding to its receptors; beta-blockers that decrease heart rate and cardiac output; calcium channel blockers that relax blood vessel muscles; and diuretics that promote sodium and water excretion to reduce blood volume. These drugs are typically prescribed for individuals with hypertension but can influence blood pressure dynamics in broader contexts through vasodilation, reduced cardiac workload, or fluid balance adjustments. They work primarily by interrupting the renin-angiotensin-aldosterone system, modulating sympathetic nervous activity, or altering ion fluxes in vascular smooth muscle cells, leading to decreased peripheral resistance or cardiac output. General health applications focus on preventing cardiovascular complications such as heart attacks, heart failure, and strokes, particularly in those with sustained high blood pressure. While primarily therapeutic agents rather than preventive supplements, their use extends to combination therapies for optimized blood pressure control.
Research summary
Scientific evidence from large-scale meta-analyses and clinical trials demonstrates that antihypertensive drugs effectively reduce systolic and diastolic blood pressure across multiple classes, with variations in efficacy for preventing major cardiovascular events. Thiazide diuretics often show superior outcomes in reducing heart attacks, heart failure, and strokes compared to ACE inhibitors, alongside better safety profiles in population-level data. Ongoing research into novel agents like aldosterone synthase inhibitors further refines options for resistant cases, though consensus emphasizes individualized selection based on patient profiles and combination intensities.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Antihypertensive drugs to your stack to report effects
Differential Effects of Antihypertensive Drugs on Central Blood Pressure: A Randomized Comparison Between Nebivolol and Telmisartan.
Unknown
Quality of Life and Antihypertensive Drug Therapy
Wassertheurer S et al.
Future of Antihypertensive Therapies.
Williams B et al.
Not All Hypertension Drugs Are Created Equal, Reports Big-Data Study
Yale School of Medicine Researchers
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials.
Ettehad D et al.
No reports yet
Be the first to report this effect and help the community.
Add Antihypertensive drugs to your stack to report effects
Antihypertensive medication adherence and associated risk factors among adults with hypertension: a cross-sectional study in a teaching hospital, Ghana.
Zhang Y et al.
Not All Hypertension Drugs Are Created Equal, Reports Big-Data Study
Yale School of Medicine Researchers
No reports yet
Be the first to report this effect and help the community.
Add Antihypertensive drugs to your stack to report effects
Quality of Life and Antihypertensive Drug Therapy
Wassertheurer S et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Antihypertensive drugs to your stack to report effects
Quality of Life and Antihypertensive Drug Therapy
Wassertheurer S et al.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Hypertension — elevated blood pressure requiring management
Not All Hypertension Drugs Are Created Equal, Reports Big-Data Study
Yale School of Medicine Researchers
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials.
Ettehad D et al.
Quality of Life and Antihypertensive Drug Therapy
Wassertheurer S et al.
Antihypertensive medication adherence and associated risk factors among adults with hypertension: a cross-sectional study in a teaching hospital, Ghana.
Zhang Y et al.
Differential Effects of Antihypertensive Drugs on Central Blood Pressure: A Randomized Comparison Between Nebivolol and Telmisartan.
Unknown
Future of Antihypertensive Therapies.
Williams B et al.
Research (6 studies)
Not All Hypertension Drugs Are Created Equal, Reports Big-Data Study
Yale School of Medicine Researchers
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials.
Ettehad D et al.
Future of Antihypertensive Therapies.
Williams B et al.
Antihypertensive medication adherence and associated risk factors among adults with hypertension: a cross-sectional study in a teaching hospital, Ghana.
Zhang Y et al.
Differential Effects of Antihypertensive Drugs on Central Blood Pressure: A Randomized Comparison Between Nebivolol and Telmisartan.
Unknown
Quality of Life and Antihypertensive Drug Therapy
Wassertheurer S et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!